Add BrightSurf on Google Email

Cleveland Clinic study suggests steroid nasal sprays may help improve outcomes in severe COVID-19 disease

A recent Cleveland Clinic study found that patients who use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including lower risk of hospitalization, ICU admission, and mortality. The study showed a 20-25% reduction in these outcomes for patients using intranasal corticosteroids.

SourceCleveland Clinic·JournalJournal of Allergy and Clinical Immunology: In Practice·DateSep 28, 2021

A bone of contention in drug-induced osteomalacia

Researchers found that SXR inhibits VDR-mediated CYP24 activity in mice, contradicting previous studies. In humans, rifampicin treatment increases CYP3A4 expression but has no effect on CYP24 expression, suggesting a complex regulatory mechanism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 11, 2006

Some CFS Patients Benefit From Low-Dose Steroid, But Side Effects Too Risky

A low-dose hydrocortisone study found slight improvement in some chronic fatigue syndrome (CFS) symptoms for about half the participants, while two-thirds on hydrocortisone reported better well-being. However, the treatment also induced adrenal suppression in twelve patients, rendering it an unsuitable option for CFS patients.